The market opened in the red on 21st January, overall volumes in futures & options currently stand at 1,75 crore contracts with a turnover of Rs. 12,81,508.03 crore.

National Buildings Construction Corporation (NBCC) Limited has received a Letter of Acceptance (LoA) from Central Coalfields Limited (CCL) worth Rs 720.32 crore, to provide Project Management Consultancy (PMC) services for the construction of smart township/colony roads, network and other road, service buildings and other allied jobs related to mines for Magadh and Amrapali area (Jharkhand).

The market opened in the red on 21st January. The previous day witnessed the Sensex going down by 416.46 points to end at 41,528.91 and the Nifty was down by 127.80 points to close at 12,224.55. 

The market opened in the red on 21st January. The previous day witnessed the Sensex going down by 416.46 points to end at 41,528.91 and the Nifty was down by 127.80 points to close at 12,224.55. 

Alembic Pharmaceuticals’ API facility located at Karkhadi was inspected by US Food and Drug Administration (USFDA) from January 13-17, 2020.

The zone of 12,200-12,216 would be a good support for the index and failure to hold this support, could open doors for further correction towards gap area of January 9 (12,132-12,045). Stocks in news: NBCC, Bharti Airtel, Info Edge, Balrampur Chini Mills.

In the last session, Indian benchmark indices tumbled from record highs to close with deep cuts. However, with yesterday’s landslide, the market participants will be anxious to know what’s in store for the markets today! The International Monetary Fund (IMF) lowered India’s economic growth forecast to 4.8 per cent for this fiscal year, citing the crisis in the non-banking financial sector and weak rural demand.

The following stocks will be in focus during Tuesday’s trading session in the light of their result announcements: Zee Entertainment Enterprises, Havells India, HDFC AMC, Polycab and Granules India.

Cipla announced that it has received Establishment Inspection Report (EIR) which indicates the closure of the inspection by United States Food and Drug Administration (USFDA) at its Patalganga (Maharashtra) manufacturing facility.